We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomarker for Prostate Cancer

By HospiMedica staff writers
Posted on 08 Nov 2004
An in vitro diagnostics (IVD) monoclonal antibody called P504s can help confirm the diagnosis of prostate cancer.

P504s can detect cancer in samples obtained from prostatectomies, needle biopsies, and transurethral prostate resections. More...
The antibody shows strong cytoplasmic granular staining in prostate cancer. It positively stains prostatic cancer cells, premalignant lesions of the prostate, high-grade intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia. The P504s protein is expressed in malignant prostate tissues, and only weakly, if at all, in benign prostatic tissue. The staining in each case is easily distinguishable.

P504s is available from Signet Laboratories, Inc. (Dedham, MA, USA), whose stated mission is to create novel diagnostics and drugs for patients at risk for cancer, sepsis and renal failure, neurodegenerative diseases such as Alzheimer's, and prion diseases such as mad cow disease.

"P504s is a highly sensitive and specific marker for prostate carcinoma with demonstrated use in detecting and clearly marking malignant tissues and atypical prostate biopsies,” stated Angela Thomas, immunohistochemistry (IHC) product manager for Signet Laboratories.




Related Links:
Signet Laboratories

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new, inexpensive stick-on sweat sensor measures lipid levels, offering a noninvasive way to continuously monitor cholesterol and triglycerides. (Image Credit: California Institute of Technology)

Wearable Patch Enables Continuous Noninvasive Cholesterol and Triglyceride Monitoring

Cholesterol and triglyceride testing typically relies on phlebotomy and intermittent lipid panels, limiting real-time assessment of cardiovascular and metabolic risk. Noninvasive monitoring could reduce... Read more

Surgical Techniques

view channel
Image: Phasix Mesh is a fully resorbable monofilament scaffold designed for rapid tissue incorporation, combining synthetic mesh repair strength with biologic graft-like remodeling. (Photo courtesy of BD)

Resorbable Mesh Evaluated to Prevent Incisional Hernias After Abdominal Surgery

Incisional hernia is a common complication after abdominal surgery and can necessitate additional interventions and prolonged recovery. Preventive strategies remain limited, and there are currently no... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.